RFP for Topical Hemostasis Surgery
Pfizer has issued an RFP for topical hemostasis in hospital outpatient and ambulatory surgery.
Grants of up to $100,000 will be awarded in support of projects to educate surgeons and other healthcare professionals on topical hemostasis in surgical procedures performed at hospital outpatient departments (HOPD) and ambulatory surgery centers (ASC) sites of care, addressing knowledge and practice gaps specific to perioperative bleeding at HOPD and ASC.
Pfizer is particularly interested in programs that focus on some or all of the management of capillary, venous, and arteriolar bleeding; preparation and use of topical hemostatic agents in HOPD and ASC operating room environment; and assessment of bleeding severity and effectiveness of topical hemostats in HOPD and ASC surgery.
Eligible applicants include medical, dental, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); professional associations and medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement.
For complete program guidelines and application instructions, see the Pfizer website.
Submissions to this sponsor/donor are managed by the Office of Corporate and Foundation Relations. Please contact your unit-assigned ASUF Director of Development or Research Advancement Specialist at your earliest convenience to ensure ASU's strategic coordination and management of funding applications.